RE: Something wrong in US FDA guidance?

From: Simon Davis Date: November 19, 2004 technical Source: cognigencorp.com
From: "Simon Davis" Subject: RE: [NMusers] Something wrong in US FDA guidance? Date: Fri, November 19, 2004 9:02 am Kyun-Seop, Bill is correct the EM algorithm is the one used by P-Pharm; in 2000 this algorithm was incorporated into InnaPhase's standard PK software Kinetica. This enables users to design and perform NCA, compartmental and population analysis through a common interface. If you would like to access a free demonstration download of Kinetica, please contact me off the list and I will be happy to explain more. This offer is open to anyone else who is interested in comparing the two applications further. http://www.innaphase.com/support_downloads_kinetica.html Best regards, Simon. ___________________________________ Simon Davis (skype = simon_davis) Senior Technical Support Scientist, Europe Thermo Electron Corporation: www.innaphase.com Cell phone : +44 7980 832 666 Facsimile : +1 801 991 7145 Office phone : +44 161 942 3000 13 Sep 2004 Thermo Electron Corporation, the world leader in analytical instruments, scientific equipment, software and services, acquired InnaPhase, bolstering the company's software offering to the life sciences industry and creating the world leading LIMS vendor. http://phx.corporate-ir.net/phoenix.zhtml?c=89145&p=irol-newsArticle&t=Regular&id=612672 _______________________________________________________
Nov 19, 2004 Kyun-Seop Bae Something wrong in US FDA guidance?
Nov 19, 2004 William Bachman RE: Something wrong in US FDA guidance?
Nov 19, 2004 Simon Davis RE: Something wrong in US FDA guidance?